Epidermal growth factor receptor expression: Predictive value for the outcome after cystectomy for bladder cancer?

BJU International

Volumn 83, Issue 4, 1999, Pages 498-503

  Sriplakich, S ^b   Jahnson, S ^a   Karlsson, M G ^b  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b NONE

Author keywords

Bladder cancer; Cystectomy; Epidermal growth factor receptor; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CELL MEMBRANE; CYSTECTOMY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR CELL; TUMOR RECURRENCE;

ADULT; AGED; CYSTECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0032989236     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00914.x     Document Type: Article

References (30)

1. 1 Wolf H, Hojgaard K. Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new recurrence. Lancet 1983; 2: 134-6
2. 2 Heney NM, Ahmed S, Flanagan M et al. Superficial bladder cancer. Progression and recurrence. J Urol 1983; 130: 1083-6
3. 3 Wijkstrom H, Edsmyr F, Lundh B. The value of preoperative classification according to the TNM system. Eur Urol 1984; 10: 101-6
4. 4 Montie JE, Wood DP. The risk of radical cystectomy. Br J Urol 1989; 63: 483-6
5. 5 Pagano F, Bassi P, Galetti TP et al. Result of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991; 145: 45-50
6. 6 Wishnow KI, Levinson AK, Johnson DE et al. Stage B (P2/3a/N0) transitional cell carcinoma of the bladder highly curable by radical cystectomy. Urology 1992; 39: 12-6
7. 7 Skinner DG, Daniels JR. Russell CA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459-64
8. 8 Lax I, Burgess WH, Bellot F, Ullrich A, Schlessinger J, Givol D. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol Cell Biol 1988; 8: 1831-4
9. 9 Chen WS, Lazar CS, Lund KA et al. Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulations. Cell 1989; 59: 33-43
10. 10 Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schults GS. Epidermal growth factor binding by breast tumour biopsies and relationship to estrogen and progestin receptor levels. Cancer Res 1984; 44: 3448-53
11. 11 Gusterson B, Cowley Smith JA, Ozanne B. Cellular localization of human epidermal growth factor receptor. Cell Biol Int Rep 1984; 8: 649-58
12. 12 Sainsbury JRC, Sherbert GV, Farndon JR, Harris JL. Epidermal growth factor receptors and oestrogen receptors in human breast carcinoma. Lancet 1985; i: 364-6
13. 13 Sainsbury JRC, Nicholson S, Angus B, Farndon JR, Malcolm AJ, Harris AL. Epidermal growth factor receptor status of histological sub-types of breast cancer. Br J Cancer 1988; 58: 458-60
14. 14 Barker S, Panahy C, Puddefoot JR, Goode AW, Vinson GP. Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast. Br J Cancer 1989; 60: 673-7
15. 15 Partridge M, Gullick WJ, Langdon JD, Sherriff M. Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1988; 26: 381-9
16. 16 Sobol RE, Astarita RW, Hodefitz C et al. Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. J Natl Cancer Inst 1987; 79: 403-7
17. 17 Cerny T, Barns DM, Hasleton P et al. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br J Cancer 1986; 54: 265-9
18. 18 Ozanne B, Richards CS, Hendler F, Burns D, Gusterson B. Over-expression of the epidermal growth factor receptor is a hallmark of squamous cell carcinomas. J Pathol 1986; 149: 9-14
19. 19 Neal DE, Marsh C, Bennett MK et al. Epidermal growth factor receptors in human bladder: Comparison of invasive and superficial tumours. Lancet 1985; i: 366-8
20. 20 Berger MS, Greenfield C, Gullick WJ et al. Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 1987; 56: 533-7
21. 21 Smith K, Fennelly JA, Neal DE, Hall RR, Harris AL. Characterisation and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumours. Cancer Res 1989; 49: 5810-5
22. 22 Neal DE, Smith K, Fennelly JA, Bennett MK, Hall RR, Harris AL. Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding. J Urol 1989; 141: 517-21
23. 23 Messing EM. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 1990; 50: 2530-7
24. 24 Nguyen PL, Swanson PE. Jaszez W et al. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: Multivariate survival analysis. Am J Clin Pathol 1994; 101: 166-76
25. 25 Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 1990; 65: 1619-25
26. 26 Wright C, Mellon K, Johnston P et al. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of human urinary bladder. Br J Cancer 1991; 63: 967-70
27. 27 Mellon K, Wright C, Kelly P, Horne CH, Neal DE. Long term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 1995; 153: 919-25
28. 28 Sauter G, Haley J. Chew K et al. Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 1994; 57: 508-14
29. 29 Lipponen P, Eskelinen M. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factor, oncoprotein (c-erbB-2, p53) expression and long term prognosis. Br J Cancer 1994; 69: 1120-5
30. 30 Moriyama M, Akiyama T, Yamamoto T et al. Expression of c-erbB-2 gene product in urinary bladder cancer. J Urol 1991; 145: 423-7